Pre-market hot trades in US stocks: Wheeler Real Estate pre-market down 25.00%; Magnitude pre-market up 24.14%

Tracking Unusual Activity
2025.09.18 08:07
portai
I'm PortAI, I can summarize articles.

Wheeler Real Estate pre-market down 25.00%; Magnitude pre-market up 24.14%; 89bio pre-market up 88.24%; InnSuites Hospitality Trust pre-market up 80.79%; AquaBounty Technology pre-market up 72.81%

Pre-market Hot Trades in US Stocks

Wheeler Real Estate is down 25% in pre-market trading. According to recent key news:

  1. On September 17, Wheeler Real Estate Investment Trust Inc. released important information through the EDGAR system of the U.S. Securities and Exchange Commission, leading to increased market concerns about its financial condition and a significant drop in stock price.

  2. On September 18, Spark's AI analyst showed a bearish trend in the technical analysis of WHLR stock, indicating that the valuation is unattractive, further exacerbating negative market sentiment.

  3. Recent analysis pointed out that although WHLR has performed strongly in operational efficiency and cash flow management, high financial leverage and low profitability pose a medium risk assessment. The real estate investment trust market is experiencing increased volatility.

Magnitude is up 24.14% in pre-market trading. No recent news.

Top Gainers in Pre-market Trading of US Stocks

89bio is up 88.24% in pre-market trading. Based on recent important news:

  1. On September 18, Roche announced the acquisition of 89bio for $14.50 per share in cash, with a total equity value of approximately $2.4 billion, and the total transaction value could reach up to $3.5 billion. This news significantly boosted 89bio's stock price. Data source: Zhitong Finance.

  2. On September 18, 89bio's key drug pegozafermin is considered likely to become the best therapy for treating moderate to severe metabolic dysfunction-associated steatotic liver disease (MASH), enhancing market confidence in its future development. Data source: Jiemian.

  3. On September 18, Roche plans to accelerate the development process of its experimental weight-loss drug, further increasing market attention on 89bio. Data source: Zhitong Finance. The biopharmaceutical industry is active in mergers and acquisitions.

AquaBounty Technologies is up 72.81% in pre-market trading. According to recent key news:

  1. On September 18, AquaBounty Technologies released its latest technical analysis report, showing a neutral view, but momentum indicators sent mixed signals. Despite poor valuation reflected in negative price-to-earnings ratios and lack of dividends, improvements in operational efficiency and cash flow management are crucial for the company's financial health. These factors led to significant stock price volatility
Source: Tracking Unusual Activity The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.